Align Technology is the leading manufacturer of clear aligners... Show more
a manufacturer of the invisalign system for treating malocclusion
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To ALGN | 1D Price Change % | ||
|---|---|---|---|---|
| ALGN | 100% | +4.36% | ||
| NVST - ALGN | 71% Closely correlated | +3.20% | ||
| XRAY - ALGN | 58% Loosely correlated | +5.40% | ||
| ICUI - ALGN | 53% Loosely correlated | +3.71% | ||
| LUNG - ALGN | 52% Loosely correlated | +3.52% | ||
| ILMN - ALGN | 48% Loosely correlated | +3.62% | ||
More | ||||
| Ticker / NAME | Correlation To ALGN | 1D Price Change % |
|---|---|---|
| ALGN | 100% | +4.36% |
| ALGN (2 stocks) | 100% Closely correlated | -2.43% |
| Pharmaceuticals: Other (50 stocks) | 68% Closely correlated | -0.80% |
| Pharmaceuticals (154 stocks) | 3% Poorly correlated | -1.37% |
On September 22, 2026, the Stochastic Oscillator for ALGN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 48 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALGN's RSI Indicator exited the oversold zone, 27 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on September 22, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 30 of 43 cases over the following month. The odds of a continued upward trend are 70%.
Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 194 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
ALGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALGN as a result. In 57 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
ALGN moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ALGN moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for ALGN entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.573) is normal, around the industry mean (4.961). P/E Ratio (26.613) is within average values for comparable stocks, (161.442). Projected Growth (PEG Ratio) (0.646) is also within normal values, averaging (4.443). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.